Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 657-665, 2007. First published February 8, 2007; 10.1373/clinchem.2006.078014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.078014v1
53/4/657    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korolainen, M. A.
Right arrow Articles by Pirttilä, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korolainen, M. A.
Right arrow Articles by Pirttilä, T.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2007;53:657-665.)
© 2007 American Association for Clinical Chemistry, Inc.


Proteomics and Protein Markers

Multiplexed Proteomic Analysis of Oxidation and Concentrations of Cerebrospinal Fluid Proteins in Alzheimer Disease

Minna A. Korolainen1,2,a, Tuula A. Nyman3,4, Paula Nyyssönen1,2, E. Samuel Hartikainen1,2 and Tuula Pirttilä1,2

1 Department of Neurology, University of Kuopio and Kuopio University Hospital, Kuopio, Finland.
2 Brain Research Unit, Clinical Research Centre/ Mediteknia, University of Kuopio, Kuopio, Finland.
3 Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
4 Finnish Institute of Occupational Health, Helsinki, Finland.

aAddress correspondence to this author at: Department of Neurology, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. Fax 358-17-162048; e-mail Minna.Korolainen{at}uku.fi.

Background: Carbonylation is an irreversible oxidative modification of proteins that has been linked to various conditions of oxidative stress, aging, physiological disorders, and disease. Increased oxidative stress is thus also considered to play a role in the pathogenesis of age-related neurodegenerative disorders such as Alzheimer disease (AD). In addition, it has recently become evident that the response mechanisms to increased oxidative stress may depend on sex. Several oxidized carbonylated proteins have been identified in plasma and brain of AD patients by use of 2-dimensional oxyblotting.

Methods: In this pilot study, we estimated the concentrations and carbonylation of the most abundant cerebrospinal fluid proteins in aging women and men, both AD patients suffering from mild dementia and individuals exhibiting no cognitive decline. Oxidized carbonylated proteins were analyzed with 2-dimensional multiplexed oxyblotting, mass spectrometry, and database searches.

Results: Signals for ß-trace, {lambda} chain, and transthyretins were decreased in probable AD patients compared with controls. The only identified protein exhibiting an increased degree of carbonylation in AD patients was {lambda} chain. The concentrations of proteins did not generally differ between men and women; however, vitamin D–binding protein, apolipoprotein A-I, and {alpha}-1-antitrypsin exhibited higher extents of carbonylation in men.

Conclusions: None of the brain-specific proteins exhibited carbonylation changes in probable AD patients compared with age-matched neurological controls showing no cognitive decline. The carbonylation status of proteins differed between women and men. Two-dimensional multiplexed oxyblotting is applicable to study both the concentrations and carbonylation of cerebrospinal fluid proteins.




The following articles in journals at HighWire Press have cited this article:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. M. Umstead, W. M. Freeman, V. M. Chinchilli, and D. S. Phelps
Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat
Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L14 - L29.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.